A detailed history of Fred Alger Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Fred Alger Management, LLC holds 398,554 shares of RGEN stock, worth $49.7 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
398,554
Previous 307,723 29.52%
Holding current value
$49.7 Million
Previous $38.8 Million 52.9%
% of portfolio
0.3%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.79 - $167.35 $10.9 Million - $15.2 Million
90,831 Added 29.52%
398,554 $59.3 Million
Q2 2024

Aug 14, 2024

SELL
$120.0 - $182.95 $14.2 Million - $21.7 Million
-118,569 Reduced 27.81%
307,723 $38.8 Million
Q1 2024

May 15, 2024

SELL
$170.78 - $208.42 $374,349 - $456,856
-2,192 Reduced 0.51%
426,292 $78.4 Million
Q4 2023

Feb 14, 2024

SELL
$114.17 - $185.35 $6.42 Million - $10.4 Million
-56,238 Reduced 11.6%
428,484 $77 Million
Q3 2023

Nov 14, 2023

SELL
$138.78 - $176.51 $11.9 Million - $15.1 Million
-85,409 Reduced 14.98%
484,722 $77.1 Million
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $2.96 Million - $3.85 Million
-21,357 Reduced 3.61%
570,131 $80.7 Million
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $27.2 Million - $34.9 Million
176,259 Added 42.45%
591,488 $99.6 Million
Q4 2022

Feb 14, 2023

SELL
$162.42 - $220.56 $12.5 Million - $17 Million
-77,067 Reduced 15.65%
415,229 $70.3 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $24.9 Million - $39.8 Million
-155,171 Reduced 23.97%
492,296 $92.1 Million
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $53.2 Million - $71.1 Million
-378,391 Reduced 36.89%
647,467 $105 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $31.1 Million - $49.7 Million
-192,784 Reduced 15.82%
1,025,858 $193 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $88 Million - $108 Million
-355,356 Reduced 22.58%
1,218,642 $323 Million
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $36.6 Million - $60.9 Million
187,901 Added 13.56%
1,573,998 $455 Million
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $15.1 Million - $20.1 Million
-91,081 Reduced 6.17%
1,386,097 $277 Million
Q1 2021

May 17, 2021

BUY
$180.37 - $226.26 $30 Million - $37.6 Million
166,364 Added 12.69%
1,477,178 $287 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $24.7 Million - $34.5 Million
166,836 Added 14.58%
1,310,814 $251 Million
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $16 Million - $20.7 Million
130,530 Added 12.88%
1,143,978 $169 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $2.12 Million - $3.16 Million
-22,499 Reduced 2.17%
1,013,448 $125 Million
Q1 2020

May 15, 2020

SELL
$84.96 - $109.14 $16.7 Million - $21.5 Million
-197,009 Reduced 15.98%
1,035,947 $100 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $10.6 Million - $13.4 Million
-143,450 Reduced 10.42%
1,232,956 $114 Million
Q3 2019

Nov 14, 2019

SELL
$76.65 - $95.51 $36.3 Million - $45.2 Million
-473,032 Reduced 25.58%
1,376,406 $106 Million
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $11.2 Million - $17.7 Million
206,393 Added 12.56%
1,849,438 $159 Million
Q1 2019

May 14, 2019

BUY
$49.45 - $62.8 $27.1 Million - $34.4 Million
548,054 Added 50.05%
1,643,045 $97.1 Million
Q4 2018

Feb 14, 2019

BUY
$48.26 - $68.88 $1.71 Million - $2.45 Million
35,503 Added 3.35%
1,094,991 $57.8 Million
Q3 2018

Nov 14, 2018

BUY
$46.8 - $58.97 $14.9 Million - $18.8 Million
318,914 Added 43.06%
1,059,488 $58.8 Million
Q2 2018

Jul 19, 2018

BUY
$35.26 - $47.04 $12.8 Million - $17.1 Million
363,339 Added 96.32%
740,574 $34.8 Million
Q1 2018

May 10, 2018

BUY
$30.92 - $37.27 $11.7 Million - $14.1 Million
377,235 New
377,235 $13.6 Million
Q4 2017

Feb 14, 2018

SELL
$32.53 - $38.92 $1.17 Million - $1.4 Million
-36,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$36.98 - $46.06 $1.33 Million - $1.66 Million
36,000
36,000 $1.38 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.